Tenaya Therapeutics to Participate in Upcoming Piper Sandler 34th Annual Healthcare Conference
November 23 2022 - 9:00AM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage
biotechnology company with a mission to discover, develop and
deliver potentially curative therapies that address the underlying
causes of heart disease, today announced that Tenaya management
will participate in the Piper Sandler 34th Annual Healthcare
Conference, taking place in New York, NY, from November 29th to
December 1st.
Details of Tenaya’s participation are as follows:
Panel Discussion: Heart to Heart with CV Players to Discuss 2023
OutlookDate: November 29, 2022Time: 2:30 – 3:25 p.m. ET
Fireside ChatDate: November 30, 2022Time: 8:30 – 8:55 a.m.
ET
A webcast of the Piper Sandler event will be available by
visiting the Investors section of Tenaya’s website. A replay of the
webcast will be available on the Tenaya website for approximately
30 days following the conference.
About Tenaya TherapeuticsTenaya Therapeutics is
a clinical-stage biotechnology company committed to a bold mission:
to discover, develop and deliver curative therapies that address
the underlying drivers of heart disease. Founded by leading
cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic cardiovascular
disorders, as well as for more prevalent heart
conditions, through three distinct but interrelated product
platforms: Gene Therapy, Cellular Regeneration and Precision
Medicine. For more information,
visit www.tenayatherapeutics.com.
Contacts |
InvestorsMichelle CorralVice President, Investor
Relations and Corporate CommunicationsTenaya
TherapeuticsIR@tenayathera.com |
|
MediaWendy RyanTen Bridge
Communicationswendy@tenbridgecommunications.com |
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Sep 2023 to Sep 2024